MTNB stock news

Matinas Biopharma Holdings, Inc. (MTNB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. Read more
Matinas BioPharma ([[MTNB]] -0.3%) inks a research collaboration agreement with ViiV Healthcare under which the latter will explore the use of the former's Read more
Matinas BioPharma Holdings, Inc. Q1 2019 Earnings Conference Call May 14, 2019 8:30 AM Company Participants Jenene Thomas - IR Jerry Jabbour - Chief Executive O Read more
Matinas Biopharma (NASDAQ:MTNB) will be announcing its earnings results before the market opens on Tuesday, April 2nd. Analysts expect the company to announce earnings of ($0.04) per share for the qua Read more
After a recent stock scan, we can see that Matinas BioPharma Holdings, Inc. (AMEX:MTNB) has a Shareholder Yield of -0.021976 and a Shareholder Yield (Mebane Faber) of -0.49507. Companies may issue new Read more
Both Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) and Eidos Therapeutics Inc. (NASDAQ:EIDX) compete on a level playing field in the Biotechnology industry. We will evaluate their performance wi Read more
Aquestive Therapeutics Inc. (NASDAQ:AQST) and Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) compete with each other in the Biotechnology sector. We will analyze and compare their profitability, Read more
Both Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) and Mersana Therapeutics Inc. (NASDAQ:MRSN) are each other’s competitor in the Biotechnology industry. Thus the compare of their profitabilit Read more

Matinas BioPharma (MTNB) Stock Price Down 5.8%

04:56pm, Saturday, 30'th Mar 2019
Matinas BioPharma Holdings Inc (NYSEAMERICAN:MTNB)’s share price traded down 5.8% during mid-day trading on Thursday . The company traded as low as $1.12 and last traded at $1.13. 804,747 shares cha Read more
This is therefore a comparing of the risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation in Abeona Therapeutics Inc. (NASDAQ:ABEO) and Matinas BioP Read more
This is a contrast between Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) and bluebird bio Inc. (NASDAQ:BLUE) based on their dividends, analyst recommendations, profitability, risk, earnings and Read more
This is therefore a contrasting of the risk, analyst recommendations, profitability, dividends, earnings and valuation, institutional ownership in Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) a Read more

Proudly made at